Dollar cost averaging (DCA) in NMRA means investing a fixed amount at regular intervals, regardless of share price. This strategy reduces timing risk and builds wealth steadily through market ups and downs.
How This Calculator Works
Our DCA calculator simulates real market conditions using historical price data. It accounts for dividend reinvestment (DRIP), where each dividend payment automatically purchases additional shares. You can adjust the investment amount, frequency, time period, and compare against benchmarks like the S&P 500 and Nasdaq-100.
More NMRA Analysis
NMRA DCA Calculator
Dollar Cost Averaging — Neumora Therapeutics, Inc. Common Stock
Same amount invested each month — only the day of purchase changes. How much does intra-month timing actually matter?
Best Timing DCA
StrategyBuy on monthly low
Total Return-42.7%
Final Value$15.2K
Perfectly timed — impossible in practice
Your DCA
StrategyBuy on 1st of month
Total Return-51.9%
Final Value$12.5K
Consistent — no timing needed
Worst Timing DCA
StrategyBuy on monthly high
Total Return-59.3%
Final Value$10.8K
Worst possible — still beats not investing
Best vs Worst gap16.6 pp
Your timing vs best-9.1%
Your timing vs worst+7.4%
If You Keep Investing…
Based on this stock's historical CAGR of -23.4%/yr — put in vs. walk away with.
Your Plan
At $500/mo, this could grow into:
3 Years$18K~1.0x your moneyfrom $18K invested
5 Years$30K~1.0x your moneyfrom $30K invested
10 Years$60K~1.0x your moneyfrom $60K invested
20 Years$120K~1.0x your moneyfrom $120K invested
Compare Other Monthly Amounts
Same CAGR assumption. Use this to pressure-test different monthly commitments.
Monthly
3 Years~1.0x your money
5 Years~1.0x your money
10 Years~1.0x your money
20 Years~1.0x your money
$100/mo
$4K+$0 est. gain
$6K+$0 est. gain
$12K+$0 est. gain
$24K+$0 est. gain
$250/mo
$9K+$0 est. gain
$15K+$0 est. gain
$30K+$0 est. gain
$60K+$0 est. gain
$500/mo
$18K+$0 est. gain
$30K+$0 est. gain
$60K+$0 est. gain
$120K+$0 est. gain
$1,000/mo
$36K+$0 est. gain
$60K+$0 est. gain
$120K+$0 est. gain
$240K+$0 est. gain
* Projection assumes historical CAGR of -23.4% continues. Actual returns will vary.
Your DCA Results by Date
33 purchases
Date
Price
Invested
Portfolio Value
% Gain
Gain ($)
Sep 15, 2023
$16.25
$10,000
$10,000
+0.00%
$0
Oct 16, 2023
$10.98
$10,500
$7,257
-30.89%
$-3,243
Nov 15, 2023
$12.01
$11,000
$8,438
-23.29%
$-2,562
Dec 15, 2023
$14.61
$11,500
$10,764
-6.40%
$-736
Jan 16, 2024
$14.05
$12,000
$10,852
-9.57%
$-1,148
Feb 15, 2024
$18.81
$12,500
$15,028
+20.23%
$2,528
Mar 15, 2024
$15.09
$13,000
$12,556
-3.41%
$-444
Apr 15, 2024
$11.19
$13,500
$9,811
-27.33%
$-3,689
May 15, 2024
$9.67
$14,000
$8,978
-35.87%
$-5,022
Jun 17, 2024
$9.38
$14,500
$9,209
-36.49%
$-5,291
Jul 15, 2024
$11.61
$15,000
$11,898
-20.68%
$-3,102
Aug 15, 2024
$11.79
$15,500
$12,583
-18.82%
$-2,917
Sep 16, 2024
$11.94
$16,000
$13,243
-17.23%
$-2,757
Oct 15, 2024
$16.08
$16,500
$18,335
+11.12%
$1,835
Nov 15, 2024
$10.84
$17,000
$12,860
-24.35%
$-4,140
Dec 16, 2024
$10.87
$17,500
$13,396
-23.45%
$-4,104
Jan 15, 2025
$2.20
$18,000
$3,211
-82.16%
$-14,789
Feb 18, 2025
$1.73
$18,500
$3,025
-83.65%
$-15,475
Mar 17, 2025
$1.19
$19,000
$2,581
-86.42%
$-16,419
Apr 15, 2025
$0.66
$19,500
$1,923
-90.14%
$-17,577
May 15, 2025
$0.67
$20,000
$2,451
-87.74%
$-17,549
Jun 16, 2025
$0.86
$20,500
$3,680
-82.05%
$-16,820
Jul 15, 2025
$1.45
$21,000
$6,678
-68.20%
$-14,322
Aug 15, 2025
$1.63
$21,500
$8,007
-62.76%
$-13,493
Sep 15, 2025
$1.52
$22,000
$7,967
-63.79%
$-14,033
Page 1 of 2
Frequently Asked Questions
Common questions about DCA investing in NMRA
Investing $500 per month in Neumora Therapeutics, Inc. Common Stock (NMRA) over the past 3 years would be worth approximately $13K today. That's -51.9% total return on $26K invested, with a -23.4% compound annual growth rate (CAGR).